Celso Arango
Celso Arango
CIBERSAM, Hospital G. U. Gregorio Marañón, Facultad de Medicina, Complutense University, Institute
Geverifieerd e-mailadres voor hggm.es - Homepage
Titel
Geciteerd door
Geciteerd door
Jaar
Common variants conferring risk of schizophrenia
H Stefansson, RA Ophoff, S Steinberg, OA Andreassen, S Cichon, ...
Nature 460 (7256), 744-747, 2009
16522009
The stress and psychological morbidity of the Alzheimer patient caregiver
MT González‐Salvador, C Arango, CG Lyketsos, AC Barba
International journal of geriatric psychiatry 14 (9), 701-710, 1999
3451999
Quality of life and disability in patients with obsessive-compulsive disorder
J Bobes, MP Gonzalez, MT Bascaran, C Arango, PA Saiz, M Bousono
European psychiatry 16 (4), 239-245, 2001
3282001
Standardized remission criteria in schizophrenia
J Van Os, T Burns, R Cavallaro, S Leucht, J Peuskens, L Helldin, ...
Acta Psychiatrica Scandinavica 113 (2), 91-95, 2006
326*2006
Violence in inpatients with schizophrenia: a prospective study
C Arango, AC Barba, T González-Salvador, AC Ordóñez
Schizophrenia Bulletin 25 (3), 493-503, 1999
3111999
The continuum of psychotic symptoms in the general population: a cross-national study
R Nuevo, S Chatterji, E Verdes, N Naidoo, C Arango, JL Ayuso-Mateos
Schizophrenia bulletin 38 (3), 475-485, 2012
3052012
Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study
J Bobes, C Arango, P Aranda, R Carmena, M Garcia-Garcia, J Rejas
Schizophrenia research 90 (1-3), 162-173, 2007
289*2007
Significance and meaning of neurological signs in schizophrenia: two decades later
I Bombin, C Arango, RW Buchanan
Schizophrenia Bulletin 31 (4), 962-977, 2005
2802005
Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study
C Torrent, CM Bonnin, A Martínez-Arán, J Valle, BL Amann, ...
American Journal of Psychiatry 170 (8), 852-859, 2013
2732013
Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy
H Ariño, N Gresa-Arribas, Y Blanco, E Martínez-Hernández, L Sabater, ...
JAMA neurology 71 (8), 1009-1016, 2014
223*2014
Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group
S Kelly, N Jahanshad, A Zalesky, P Kochunov, I Agartz, C Alloza, ...
Molecular psychiatry 23 (5), 1261-1269, 2018
2222018
Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns
B Vitiello, C Correll, B van Zwieten-Boot, A Zuddas, M Parellada, ...
European Neuropsychopharmacology 19 (9), 629-635, 2009
2152009
Common variants at VRK2 and TCF4 conferring risk of schizophrenia
S Steinberg, S de Jong, OA Andreassen, T Werge, AD Børglum, O Mors, ...
Human molecular genetics 20 (20), 4076-4081, 2011
2112011
Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort
J Bobes, C Arango, M Garcia-Garcia, J Rejas
Schizophrenia research 119 (1-3), 101-109, 2010
2012010
ECNP consensus meeting. Bipolar depression. Nice, March 2007
GM Goodwin, I Anderson, C Arango, CL Bowden, C Henry, PB Mitchell, ...
European Neuropsychopharmacology 18 (7), 535-549, 2008
1972008
Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to …
D Fraguas, CU Correll, J Merchán-Naranjo, M Rapado-Castro, ...
European Neuropsychopharmacology 21 (8), 621-645, 2011
1852011
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
M Di Forti, D Quattrone, TP Freeman, G Tripoli, C Gayer-Anderson, ...
The Lancet Psychiatry 6 (5), 427-436, 2019
1792019
Advantages and disadvantages of combination treatment with antipsychotics: ECNP Consensus Meeting, March 2008, Nice
G Goodwin, W Fleischhacker, C Arango, P Baumann, M Davidson, ...
European Neuropsychopharmacology 19 (7), 520-532, 2009
1692009
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations
European Network of National Networks studying Gene-Environment Interactions ...
Schizophrenia Bulletin 40 (4), 729-736, 2014
1652014
Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study
J Bobes, C Arango, M Garcia-Garcia, J Rejas
The Journal of clinical psychiatry 71 (3), 280-286, 2009
1542009
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20